162 related articles for article (PubMed ID: 37168549)
1. Combinatorial drug screening on 3D Ewing sarcoma spheroids using droplet-based microfluidics.
Fevre R; Mary G; Vertti-Quintero N; Durand A; Tomasi RF; Del Nery E; Baroud CN
iScience; 2023 May; 26(5):106651. PubMed ID: 37168549
[TBL] [Abstract][Full Text] [Related]
2. Simple droplet microfluidics platform for drug screening on cancer spheroids.
Parent C; Raj Melayil K; Zhou Y; Aubert V; Surdez D; Delattre O; Wilhelm C; Viovy JL
Lab Chip; 2023 Dec; 23(24):5139-5150. PubMed ID: 37942508
[TBL] [Abstract][Full Text] [Related]
3. Individual Control and Quantification of 3D Spheroids in a High-Density Microfluidic Droplet Array.
Tomasi RF; Sart S; Champetier T; Baroud CN
Cell Rep; 2020 May; 31(8):107670. PubMed ID: 32460010
[TBL] [Abstract][Full Text] [Related]
4. Rapid Production and Recovery of Cell Spheroids by Automated Droplet Microfluidics.
Langer K; Joensson HN
SLAS Technol; 2020 Apr; 25(2):111-122. PubMed ID: 31561747
[TBL] [Abstract][Full Text] [Related]
5. Bionic 3D spheroids biosensor chips for high-throughput and dynamic drug screening.
Wu Q; Wei X; Pan Y; Zou Y; Hu N; Wang P
Biomed Microdevices; 2018 Sep; 20(4):82. PubMed ID: 30220069
[TBL] [Abstract][Full Text] [Related]
6. A novel design of microfluidic platform for metronomic combinatorial chemotherapy drug screening based on 3D tumor spheroid model.
Sankar S; Mehta V; Ravi S; Sharma CS; Rath SN
Biomed Microdevices; 2021 Oct; 23(4):50. PubMed ID: 34596764
[TBL] [Abstract][Full Text] [Related]
7. Facile One Step Formation and Screening of Tumor Spheroids Using Droplet-Microarray Platform.
Popova AA; Tronser T; Demir K; Haitz P; Kuodyte K; Starkuviene V; Wajda P; Levkin PA
Small; 2019 Jun; 15(25):e1901299. PubMed ID: 31058427
[TBL] [Abstract][Full Text] [Related]
8. Generation of 3D Spheroids Using a Thiol-Acrylate Hydrogel Scaffold to Study Endocrine Response in ER
Khan AH; Zhou SP; Moe M; Ortega Quesada BA; Bajgiran KR; Lassiter HR; Dorman JA; Martin EC; Pojman JA; Melvin AT
ACS Biomater Sci Eng; 2022 Sep; 8(9):3977-3985. PubMed ID: 36001134
[TBL] [Abstract][Full Text] [Related]
9. High-Throughput Measurements of Intra-Cellular and Secreted Cytokine from Single Spheroids Using Anchored Microfluidic Droplets.
Saint-Sardos A; Sart S; Lippera K; Brient-Litzler E; Michelin S; Amselem G; Baroud CN
Small; 2020 Dec; 16(49):e2002303. PubMed ID: 33185938
[TBL] [Abstract][Full Text] [Related]
10. Signature-based small molecule screening identifies cytosine arabinoside as an EWS/FLI modulator in Ewing sarcoma.
Stegmaier K; Wong JS; Ross KN; Chow KT; Peck D; Wright RD; Lessnick SL; Kung AL; Golub TR
PLoS Med; 2007 Apr; 4(4):e122. PubMed ID: 17425403
[TBL] [Abstract][Full Text] [Related]
11. High-throughput microfluidics for evaluating microbubble enhanced delivery of cancer therapeutics in spheroid cultures.
Bourn MD; Batchelor DVB; Ingram N; McLaughlan JR; Coletta PL; Evans SD; Peyman SA
J Control Release; 2020 Oct; 326():13-24. PubMed ID: 32562855
[TBL] [Abstract][Full Text] [Related]
12. A high-throughput, open-space and reusable microfluidic chip for combinational drug screening on tumor spheroids.
Li L; Chen Y; Wang H; An G; Wu H; Huang W
Lab Chip; 2021 Oct; 21(20):3924-3932. PubMed ID: 34636818
[TBL] [Abstract][Full Text] [Related]
13. Recent methods of droplet microfluidics and their applications in spheroids and organoids.
Wang Y; Liu M; Zhang Y; Liu H; Han L
Lab Chip; 2023 Mar; 23(5):1080-1096. PubMed ID: 36628972
[TBL] [Abstract][Full Text] [Related]
14. High-throughput RNAi screen in Ewing sarcoma cells identifies leucine rich repeats and WD repeat domain containing 1 (LRWD1) as a regulator of EWS-FLI1 driven cell viability.
He T; Surdez D; Rantala JK; Haapa-Paananen S; Ban J; Kauer M; Tomazou E; Fey V; Alonso J; Kovar H; Delattre O; Iljin K
Gene; 2017 Jan; 596():137-146. PubMed ID: 27760381
[TBL] [Abstract][Full Text] [Related]
15. Etoposide and carbo-or cisplatin combination therapy in refractory or relapsed Ewing sarcoma: a large retrospective study.
van Maldegem AM; Benson C; Rutkowski P; Blay JY; van den Berg H; Placzke J; Rasper M; Judson I; Juergens H; Dirksen U; Gelderblom H
Pediatr Blood Cancer; 2015 Jan; 62(1):40-4. PubMed ID: 25251256
[TBL] [Abstract][Full Text] [Related]
16. Sequential operation droplet array: an automated microfluidic platform for picoliter-scale liquid handling, analysis, and screening.
Zhu Y; Zhang YX; Cai LF; Fang Q
Anal Chem; 2013 Jul; 85(14):6723-31. PubMed ID: 23763273
[TBL] [Abstract][Full Text] [Related]
17. The Role of C-X-C Chemokine Receptor Type 4 (CXCR4) in Cell Adherence and Spheroid Formation of Human Ewing's Sarcoma Cells under Simulated Microgravity.
Romswinkel A; Infanger M; Dietz C; Strube F; Kraus A
Int J Mol Sci; 2019 Dec; 20(23):. PubMed ID: 31810195
[TBL] [Abstract][Full Text] [Related]
18. Cholecystokinin down-regulation by RNA interference impairs Ewing tumor growth.
Carrillo J; García-Aragoncillo E; Azorín D; Agra N; Sastre A; González-Mediero I; García-Miguel P; Pestaña A; Gallego S; Segura D; Alonso J
Clin Cancer Res; 2007 Apr; 13(8):2429-40. PubMed ID: 17438102
[TBL] [Abstract][Full Text] [Related]
19. Microfluidically-generated Encapsulated Spheroids (μ-GELS): An All-Aqueous Droplet Microfluidics Platform for Multicellular Spheroids Generation.
Kieda J; Appak-Baskoy S; Jeyhani M; Navi M; Chan KWY; Tsai SSH
ACS Biomater Sci Eng; 2023 Feb; 9(2):1043-1052. PubMed ID: 36626575
[TBL] [Abstract][Full Text] [Related]
20. In-air production of 3D co-culture tumor spheroid hydrogels for expedited drug screening.
Antunes J; Gaspar VM; Ferreira L; Monteiro M; Henrique R; Jerónimo C; Mano JF
Acta Biomater; 2019 Aug; 94():392-409. PubMed ID: 31200118
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
